<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gnck</journal-id><journal-title-group><journal-title xml:lang="ru">Колопроктология</journal-title><trans-title-group xml:lang="en"><trans-title>Koloproktologia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7556</issn><issn pub-type="epub">2686-7303</issn><publisher><publisher-name>Russian Association of Coloproctology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33878/2073-7556-2022-21-4-130-138</article-id><article-id custom-type="elpub" pub-id-type="custom">gnck-1742</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ И МЕТААНАЛИЗ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS AND METAANALYSIS</subject></subj-group></article-categories><title-group><article-title>Опыт выполнения реконструктивной операции — наданального колоректального анастомоза у больного гемофилией А, осложненной выработкой ингибитора  к FVIII (обзор литературы с описанием клинического случая)</article-title><trans-title-group xml:lang="en"><trans-title>Stoma takedown after Hartmann’s procedure in a patient with hemophilia A complicated with production  of inhibitor to FVIII (review and case report)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4272-8433</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Штыркова</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shtyrkova</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Штыркова Светлана Витальевна - к.м.н., врач колопроктолог хирургического отделения</p><p>Новый Зыковский проезд, д.4, г. Москва, 125167</p><p>тел. моб.: + 7 (916) 136-04-21, тел. раб.: +7 (495) 612-61-91</p></bio><bio xml:lang="en"><p>Shtyrkova Svetlana V.</p><p>Novy Zykovsky proezd, 4, Moscow, 125167</p><p>mobile: +7 (916) 136-04-21, office: +7 (495) 612-61-91</p></bio><email xlink:type="simple">shtyrkova.s@blood.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5347-2947</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шутов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shutov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., ведущий научный сотрудник хирургического отделения</p><p>Новый Зыковский проезд, д. 4, г. Москва, 125167</p></bio><bio xml:lang="en"><p>Novy Zykovsky proezd, 4, Moscow, 125167</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5379-4981</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батров</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Batrov</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Батров Павел Александрович — врач-хирург хирургического отделения</p><p>Новый Зыковский проезд, д. 4, г. Москва, 125167</p></bio><bio xml:lang="en"><p>Novy Zykovsky proezd, 4, Moscow, 125167</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3919-9067</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рыбаков</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Rybakov</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор Российской Академии Наук; руководитель отдела онкопроктологии</p><p>ул. Саляма Адиля, д. 2, г. Москва, 123423</p></bio><bio xml:lang="en"><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6284-3474</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прасолов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Prasolov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач анестезиолог-реаниматолог отделения анестезиологии и реанимации</p><p>Новый Зыковский проезд, д. 4, г. Москва, 125167</p></bio><bio xml:lang="en"><p>Novy Zykovsky proezd, 4, Moscow, 125167</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НMИЦ гематологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Hematology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ колопроктологии имени А.Н. Рыжих» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Coloproctology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>21</day><month>12</month><year>2022</year></pub-date><volume>21</volume><issue>4</issue><fpage>130</fpage><lpage>138</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Штыркова С.В., Шутов С.А., Батров П.А., Рыбаков Е.Г., Прасолов Н.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Штыркова С.В., Шутов С.А., Батров П.А., Рыбаков Е.Г., Прасолов Н.В.</copyright-holder><copyright-holder xml:lang="en">Shtyrkova S.V., Shutov S.A., Batrov P.A., Rybakov E.G., Prasolov N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ruproctology.com/jour/article/view/1742">https://www.ruproctology.com/jour/article/view/1742</self-uri><abstract><p>Возможным специфическим проявлением гемофилии А является формирование спонтанной гематомы брюшной полости, имитирующей клиническую картину различных острых хирургических заболеваний. Появлением ауто-антител к FVIII приводит к утрате ответа на заместительную гемостатическую терапию и требует индивидуально-ориентированного подхода к лечению, а также высокочувствительных технологий лабораторного мониторинга для уменьшения риска неконтролируемого кровотечения при проведение хирургических вмешательств. В статье представлен опыт многоэтапного хирургического лечения такого осложнения.</p></abstract><trans-abstract xml:lang="en"><p>One of the specific manifestations of hemophilia A is the spontaneous abdominal hematoma mimicking the clinical picture of acute abdominal disease. The appearance of auto-antibodies to FVIII leads to a loss of response to replacement hemostatic therapy and requires an individualized approach as well as highly sensitive laboratory monitoring to reduce the risk of uncontrolled bleeding. The paper presents the case of multi-stage surgical treatment of this complication.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гемофилия</kwd><kwd>ингибиторная форма гемофилии</kwd><kwd>колоректальный анастомоз</kwd><kwd>несостоятельность анастомоза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Hemophilia</kwd><kwd>inhibitor form of hemophilia</kwd><kwd>colorectal anastomosis</kwd><kwd>anastomosis failure</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Iorio A, Stonebraker JS, Chambost H, et al. Data and Demographics Committee of the World Federation of Hemophilia. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Ann Intern Med. 2019 Oct 15;171(8):540-546. DOI: 10.7326/M19-1208. Epub 2019 Sep 10. PMID: 31499529</mixed-citation><mixed-citation xml:lang="en">Iorio A, Stonebraker JS, Chambost H, et al. Data and Demographics Committee of the World Federation of Hemophilia. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Ann Intern Med. 2019 Oct 15;171(8):540-546. DOI: 10.7326/M19-1208. Epub 2019 Sep 10. PMID: 31499529</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Berntorp E, Fischer K, Hart DP, et al. Haemophilia. Nat Rev Dis Primers. 2021 Jun 24;7(1):45. DOI: 10.1038/s41572-021-00278-x. PMID: 34168126.</mixed-citation><mixed-citation xml:lang="en">Berntorp E, Fischer K, Hart DP, et al. Haemophilia. Nat Rev Dis Primers. 2021 Jun 24;7(1):45. DOI: 10.1038/s41572-021-00278-x. PMID: 34168126.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Зозуля Н.И., Свирин П.В. Клинические рекомендации по диагностике и лечению гемофилии. Под ред. Савченко В.Г. 2014 г.</mixed-citation><mixed-citation xml:lang="en">Zozulya N.I., Svirin P.V. Clinical recommendations for the diagnosis and treatment of hemophilia. Ed. Savchenko V.G. 2014. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шутов С.А., Карагюлян С.Р., Данишян К.И. Особенности лечения острых хирургических заболеваний органов брюшной полости у больных гемофилией. Хирургия. 2014; (3): 25-31.</mixed-citation><mixed-citation xml:lang="en">Shutov S.A., Karagyulyan S.R., Danishyan K.I. Features of treatment of acute surgical diseases of abdominal organs in patients with hemophilia. Surgery. 2014; (3): 25-31. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Eckhardt CL, Loomans JI, van Velzen AS, et al. INSIGHT Study Group. Inhibitor development and mortality in non-severe hemophilia A. J Thromb Haemost. 2015 Jul;13(7):1217-25. DOI: 10.1111/jth.12990. Epub 2015 Jun 10. PMID: 25912309.</mixed-citation><mixed-citation xml:lang="en">Eckhardt CL, Loomans JI, van Velzen AS, et al. INSIGHT Study Group. Inhibitor development and mortality in non-severe hemophilia A. J Thromb Haemost. 2015 Jul;13(7):1217-25. DOI: 10.1111/jth.12990. Epub 2015 Jun 10. PMID: 25912309.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Takedani H, Shima M, Horikoshi Y, et al. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan. Haemophilia. 2015 May;21(3):374-9. DOI: 10.1111/hae.12611. Epub 2014 Dec 18. PMID: 25521821.</mixed-citation><mixed-citation xml:lang="en">Takedani H, Shima M, Horikoshi Y, et al. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan. Haemophilia. 2015 May;21(3):374-9. DOI: 10.1111/hae.12611. Epub 2014 Dec 18. PMID: 25521821.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Буланов А.Ю., Городецкий В.М., Щербакова О.В. Тромбоэластографическая оценка системы гемостаза и эффективности ее стандартной коррекции перед оперативными вмешательствами у больных с заболеваниями системы крови. Гематология и трансфузиология. 2012;57(5):36-42.</mixed-citation><mixed-citation xml:lang="en">Bulanov A.Yu., Gorodetsky V.M., Shcherbakova O.V. Thromboelastographic evaluation of the hemostasis system and the effectiveness of its standard correction before surgical interventions in patients with diseases of the blood system. Hematology and transfusiology. 2012;57(5):36-42. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chapin J, Bamme J, Hsu F, Christos P, et al. Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures. Clin Appl Thromb Hemost. 2017 Mar;23(2):148-154. DOI: 10.1177/1076029616658116. Epub 2016 Jul 19. PMID: 27418638</mixed-citation><mixed-citation xml:lang="en">Chapin J, Bamme J, Hsu F, Christos P, et al. Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures. Clin Appl Thromb Hemost. 2017 Mar;23(2):148-154. DOI: 10.1177/1076029616658116. Epub 2016 Jul 19. PMID: 27418638</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Тарасов М.А., Пикунов Д.Ю., Зароднюк И.В. и соавт. Факторы риска несостоятельности низких колоректальных анастомозов. Клиническая и экспериментальная хирургия. Журнал имени академика Б.В. Петровского. 2016; 4(2): 80-88.</mixed-citation><mixed-citation xml:lang="en">Tarasov M.A., Pikunov D.Yu., Zarodnyuk I.V. et al. Risk factors for the failure of low colorectal anastomoses. Clinical and experimental surgery. Journal named after Academician B.V. Petrovsky. 2016; 4(2): 80-88. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tekkis P, Tan E, Kontovounisios C, Kinross J, et al. Hand-sewn coloanal anastomosis for low rectal cancer: technique and long-term outcome. Colorectal Dis. 2015 Dec;17(12):1062-70. DOI: 10.1111/codi.13028. PMID: 26096142.</mixed-citation><mixed-citation xml:lang="en">Tekkis P, Tan E, Kontovounisios C, Kinross J, et al. Hand-sewn coloanal anastomosis for low rectal cancer: technique and long-term outcome. Colorectal Dis. 2015 Dec;17(12):1062-70. DOI: 10.1111/codi.13028. PMID: 26096142.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Алексеев М.В., Шелыгин Ю.А., Рыбаков Е.Г. Методы профилактики несостоятельности колоректального анастомоза (обзор литературы). Колопроктология. 2015;4(54):46-56.</mixed-citation><mixed-citation xml:lang="en">Alekseev M.V., Shelygin Yu.A., Rybakov E.G. Methods of preventing the insolvency of colorectal anastomosis (literature review). Koloproktologia. 2015;4(54):46-56. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gavriilidis P, Azoulay D, Taflampas P. Loop transverse colostomy versus loop ileostomy for defunctioning of colorectal anastomosis: a systematic review, updated conventional meta-analysis, and cumulative meta-analysis. Surg Today. 2019 Feb;49(2):108-117. DOI: 10.1007/s00595-018-1708-x. Epub 2018 Aug 27. PMID: 30151626.</mixed-citation><mixed-citation xml:lang="en">Gavriilidis P, Azoulay D, Taflampas P. Loop transverse colostomy versus loop ileostomy for defunctioning of colorectal anastomosis: a systematic review, updated conventional meta-analysis, and cumulative meta-analysis. Surg Today. 2019 Feb;49(2):108-117. DOI: 10.1007/s00595-018-1708-x. Epub 2018 Aug 27. PMID: 30151626.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Abdi A, Linari S, Pieri L, Voorberg J, et al. Inhibitors in Nonsevere Hemophilia A: What Is Known and Searching for the Unknown. Semin Thromb Hemost. 2018 Sep;44(6):568-577. DOI: 10.1055/s-0037-1621717. Epub 2018 Feb 13. PMID: 29439277</mixed-citation><mixed-citation xml:lang="en">Abdi A, Linari S, Pieri L, Voorberg J, et al. Inhibitors in Nonsevere Hemophilia A: What Is Known and Searching for the Unknown. Semin Thromb Hemost. 2018 Sep;44(6):568-577. DOI: 10.1055/s-0037-1621717. Epub 2018 Feb 13. PMID: 29439277</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Négrier C, Lienhart A, Numerof R, et al. Surgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies. Haemophilia. 2013 May;19(3):e143-50. DOI: 10.1111/hae.12080. Epub 2013 Jan 3. PMID: 23282031.</mixed-citation><mixed-citation xml:lang="en">Négrier C, Lienhart A, Numerof R, et al. Surgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies. Haemophilia. 2013 May;19(3):e143-50. DOI: 10.1111/hae.12080. Epub 2013 Jan 3. PMID: 23282031.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Valentino L, Cooper D, Goldstein B. Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia. 2011;17(4):579-589. DOI: 10.1111/j.1365-2516.2010.02460.x</mixed-citation><mixed-citation xml:lang="en">Valentino L, Cooper D, Goldstein B. Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia. 2011;17(4):579-589. DOI: 10.1111/j.1365-2516.2010.02460.x</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lison S, Spannagl M. Perioperatives Management bei Patienten mit Hämophilie [Perioperative management of patients with hemophilia]. Anaesthesist. 2014 Jan;63(1):6-15. German. DOI: 10.1007/s00101-013-2256-9. PMID: 24270937.</mixed-citation><mixed-citation xml:lang="en">Lison S, Spannagl M. Perioperatives Management bei Patienten mit Hämophilie [Perioperative management of patients with hemophilia]. Anaesthesist. 2014 Jan;63(1):6-15. German. DOI: 10.1007/s00101-013-2256-9. PMID: 24270937.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher C, Mo A, Warrillow S, Smith C, et al. Utility of thromboelastography in managing acquired Factor VIII inhibitor associated massive haemorrhage. Anaesth Intensive Care. 2013 Nov;41(6):799-803. DOI: 10.1177/0310057X1304100617. PMID: 24180723</mixed-citation><mixed-citation xml:lang="en">Fisher C, Mo A, Warrillow S, Smith C, et al. Utility of thromboelastography in managing acquired Factor VIII inhibitor associated massive haemorrhage. Anaesth Intensive Care. 2013 Nov;41(6):799-803. DOI: 10.1177/0310057X1304100617. PMID: 24180723</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Galstyan G.M., Polevodova O.A., Terekhova I.V. et al. The use of thromboelastography, thrombin generation test and clotting tests to evaluate the efficacy of hemostatic therapy with recombinant activated factor VII in hemophilia patients with inhibitor. Russian Journal of Pediatric Hematology and Oncology. 2017;4(4):33-38. (In Russ.) https://doi.org/10.17650/2311-1267-2017-4-4-33-38</mixed-citation><mixed-citation xml:lang="en">Galstyan G.M., Polevodova O.A., Terekhova I.V. et al. The use of thromboelastography, thrombin generation test and clotting tests to evaluate the efficacy of hemostatic therapy with recombinant activated factor VII in hemophilia patients with inhibitor. Russian Journal of Pediatric Hematology and Oncology. 2017;4(4):33-38. (In Russ.) https://doi.org/10.17650/2311-1267-2017-4-4-33-38</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
